Gene
SPRR2D
Entrez Gene ID | 6703 (See on NCBI) |
Description | small proline-rich protein 2D |
Gene Synonyms | |
Node consisting of this Gene | SPRR2D SPRR2F///SPRR2D///SPRR2B SPRR2D///SPRR2B |
Networks including this gene
GSE12470_top8000 - GSE12470 - SiGN-BN NNSR | Gene expression profiles of serous ovarian cancer samples |
GSE13601_top8000 - GSE13601 - SiGN-BN NNSR | Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators |
GSE15212_top8000 - GSE15212 - SiGN-BN NNSR | Identification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer |
GSE20842_top8000 - GSE20842 - SiGN-BN NNSR | Mutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas |
GSE21501_top8000 - GSE21501 - SiGN-BN NNSR | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma |
GSE23772_top8000 - GSE23772 - SiGN-BN NNSR | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
GSE26549_top8000 - GSE26549 - SiGN-BN NNSR | Gene Expression Profiling Predicts the Development of Oral Cancer |
GSE29817_top8000 - GSE29817 - SiGN-BN NNSR | Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer |
GSE3143_top8000 - GSE3143 - SiGN-BN NNSR | Breast Cancer Dataset |
GSE31552_top8000 - GSE31552 - SiGN-BN NNSR | Expression Data from human Lung tissue of Patients with Non Small Cell Lung Cancer (NSCLC) |
GSE7604_top8000 - GSE7604 - SiGN-BN NNSR | Human Colon tumor vs Normal Human DNA |
GSE7606_top8000 - GSE7606 - SiGN-BN NNSR | Human Melanoma vs Normal Human DNA |
GSE7849_top8000 - GSE7849 - SiGN-BN NNSR | Age-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors |
GSE8057_top8000 - GSE8057 - SiGN-BN NNSR | Expression data from ovarian cancer cells with time-course and concentration-profiles |
GSE8546_top8000 - GSE8546 - SiGN-BN NNSR | Gene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure |
GSE10972_egf1520 - GSE10972 - SiGN-BN HC+Bootstrap | Colon cancer |
GSE12391_egf1520 - GSE12391 - SiGN-BN HC+Bootstrap | Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi |
GSE12428_egf1520 - GSE12428 - SiGN-BN HC+Bootstrap | Current smoking-specific gene expression signature in bronchial epithelium is enhanced in squamous cell lung cancer |
GSE12470_egf1520 - GSE12470 - SiGN-BN HC+Bootstrap | Gene expression profiles of serous ovarian cancer samples |
GSE12622_egf1520 - GSE12622 - SiGN-BN HC+Bootstrap | Tumor-associated stroma derived from primary clinical breast cancer samples (II) |
GSE13507_egf1520 - GSE13507 - SiGN-BN HC+Bootstrap | Predective Value of Prognosis-Related Gene Expression Study in Primary Bladder Cancer |
GSE13598_egf1520 - GSE13598 - SiGN-BN HC+Bootstrap | mRNA expression of 131 cancer cell lines |
GSE13601_egf1520 - GSE13601 - SiGN-BN HC+Bootstrap | Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators |
GSE13861_egf1520 - GSE13861 - SiGN-BN HC+Bootstrap | Gene expression signature-based novel prognostic risk score in gastric cancer |
GSE13898_egf1520 - GSE13898 - SiGN-BN HC+Bootstrap | Robust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome |
GSE14206_egf1520 - GSE14206 - SiGN-BN HC+Bootstrap | Analysis of ETS gene expression patterns uncovers novel ETS mediated gene silencing pathways in prostate cancers |
GSE15212_egf1520 - GSE15212 - SiGN-BN HC+Bootstrap | Identification and validation of NOL5A and RPS2 as potential therapeutic targtes in colorectal cancer |
GSE15966_egf1520 - GSE15966 - SiGN-BN HC+Bootstrap | Gene expression signature predictive of rapid response to imatinib mesylate in Gastrointestinal Stromal Tumor (GIST) |
GSE16120_egf1520 - GSE16120 - SiGN-BN HC+Bootstrap | Gene profiling, mutations and expression of epidermal growth factor receptor in androgen-dependent prostate cancer |
GSE16757_egf1520 - GSE16757 - SiGN-BN HC+Bootstrap | Gene expression study in hepatocellular carcinoma |
GSE16987_egf1520 - GSE16987 - SiGN-BN HC+Bootstrap | A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis |
GSE17764_egf1520 - GSE17764 - SiGN-BN HC+Bootstrap | Expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients |
GSE18684_egf1520 - GSE18684 - SiGN-BN HC+Bootstrap | Fine mapping of androgen regulated genes in LNCaP cells |
GSE19274_egf1520 - GSE19274 - SiGN-BN HC+Bootstrap | Expression profiling in Neuroblastoma Primary tumors and Cell lines |
GSE19417_egf1520 - GSE19417 - SiGN-BN HC+Bootstrap | Human esophageal adenocarcinomas |
GSE19494_egf1520 - GSE19494 - SiGN-BN HC+Bootstrap | Subcutaneous adipose tissue (SAT) gene expression patterns between weight control and regaining weight subjects |
GSE20842_egf1520 - GSE20842 - SiGN-BN HC+Bootstrap | Mutated KRAS induces overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas |
GSE21501_egf1520 - GSE21501 - SiGN-BN HC+Bootstrap | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma |
GSE22153_egf1520 - GSE22153 - SiGN-BN HC+Bootstrap | Gene Experssion Profiling-Based Identification of Molecular Subtypes in Stage IV Melanoma with Different Clinical Outcome (test set) |
GSE23772_egf1520 - GSE23772 - SiGN-BN HC+Bootstrap | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
GSE23991_egf1520 - GSE23991 - SiGN-BN HC+Bootstrap | Effect of zebularine on primary human liver cancer cell lines |
GSE24124_egf1520 - GSE24124 - SiGN-BN HC+Bootstrap | Major gene partners of a favorable biomarker in ER(+) breast cancer |
GSE27480_egf1520 - GSE27480 - SiGN-BN HC+Bootstrap | Gene-expression analysis of Oncostatin-M (OSM) signalling in cervical squamous cell carcinomas over-expressing the Oncostatin-M receptor (OSMR) |
GSE29288_egf1520 - GSE29288 - SiGN-BN HC+Bootstrap | Comparison between cell lines from 9 different cancer tissue (NCI-60) (Agilent WG platform) |
GSE29817_egf1520 - GSE29817 - SiGN-BN HC+Bootstrap | Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor (EGFR) Predicts Outcome after Chemoradiotherapy of Lymph Node Negative Cervical Cancer |
GSE31245_egf1520 - GSE31245 - SiGN-BN HC+Bootstrap | Unique gene expression profile based upon pathologic response in epithelial ovarian cancer |
GSE31279_egf1520 - GSE31279 - SiGN-BN HC+Bootstrap | Decoding differentially regulated epithelial and stromal pathways in colorectal cancer |
GSE3143_egf1520 - GSE3143 - SiGN-BN HC+Bootstrap | Breast Cancer Dataset |
GSE3960_egf1520 - GSE3960 - SiGN-BN HC+Bootstrap | Classification of neuroblastoma by integrating gene expression pattern with regional alterations in DNA copy number |
GSE4823_egf1520 - GSE4823 - SiGN-BN HC+Bootstrap | Comparison of normal breast epithelium and stroma from reduction and I.D.C. cases |
GSE7604_egf1520 - GSE7604 - SiGN-BN HC+Bootstrap | Human Colon tumor vs Normal Human DNA |
GSE7606_egf1520 - GSE7606 - SiGN-BN HC+Bootstrap | Human Melanoma vs Normal Human DNA |
GSE7849_egf1520 - GSE7849 - SiGN-BN HC+Bootstrap | Age-Specific Differences of Oncogenic Pathway Deregulation Seen in Human Breast Tumors |
GSE8057_egf1520 - GSE8057 - SiGN-BN HC+Bootstrap | Expression data from ovarian cancer cells with time-course and concentration-profiles |
GSE8546_egf1520 - GSE8546 - SiGN-BN HC+Bootstrap | Gene Expression Changes in Myeloma Cells Following Short Term In-vivo Drug Exposure |
GSE9014_egf1520 - GSE9014 - SiGN-BN HC+Bootstrap | Tumor-associated stroma derived from primary clinical breast cancer samples |
GSE9309_egf1520 - GSE9309 - SiGN-BN HC+Bootstrap | Recovery of biological information under heterogeneous experimental conditions using subgroup standardization. |
(57 networks)